Drug Shortage Report for NAT-DONEPEZIL
Report ID | 55625 |
Drug Identification Number | 02439557 |
Brand name | NAT-DONEPEZIL |
Common or Proper name | DONEPEZIL HYDROCHLORIDE TABLETS |
Company Name | NATCO PHARMA (CANADA) INC |
Market Status | MARKETED |
Active Ingredient(s) | DONEPEZIL HYDROCHLORIDE |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | Bottle of 100s |
ATC code | N06DA |
ATC description | ANTI-DEMENTIA DRUGS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-07-13 |
Estimated end date | 2020-10-01 |
Actual end date | 2020-10-02 |
Shortage status | Resolved |
Updated date | 2020-10-26 |
Company comments | Resolved |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2000 ARGENTIA ROAD, PLAZA 1, SUITE 200 MISSISSAUGA, ONTARIO CANADA L5N 1P7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2020-10-26 | French | Compare |
v7 | 2020-10-26 | English | Compare |
v6 | 2020-10-26 | French | Compare |
v5 | 2020-10-26 | English | Compare |
v4 | 2018-07-14 | English | Compare |
v3 | 2018-07-13 | French | Compare |
v2 | 2018-07-13 | English | Compare |
v1 | 2018-07-13 | English | Compare |
Showing 1 to 8 of 8